Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,059 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06875167Recruiting
Automated insulin therapy for kids 2-6 with type 1 diabetes
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
Nice, FranceAges 2–6 - NCT06452654RecruitingPhase 4
Vaccine to prevent type 1 diabetes in high-risk babies
This study tests whether a vaccine given to very young babies (3–4 months old) can prevent type 1 diabetes. It is designed for babies who have a high genetic risk and a family history of the disease.
ViennaAges 3 months–4 months - NCT05799222Recruiting
Nutrition program for obesity and diabetes risk
This trial tests a medically guided nutrition program to help improve weight and blood sugar in adults with obesity or early diabetes risk. It specifically targets people who meet income guidelines and don’t already use most diabetes or anti-obesity medicines.
Boston, MassachusettsAges 18–65 - NCT02166372Recruiting
Testing weight-loss surgery vs standard care for type 2 diabetes
This study compares people with type 2 diabetes and higher body weight who meet criteria for metabolic (weight-loss) surgery versus people with mild obesity who do not. It aims to see whether surgery improves diabetes-related outcomes more than usual medical care.
Taoyuan CityAges 20–67 - NCT04931537Recruiting
Testing early kidney marker tests for people with diabetes
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
HangzhouAges 18–80 - NCT07544407Enrolling by invitation
Text-Based Diabetes Support for Parents
This study helps parents newly diagnosed with type 2 diabetes learn to manage their condition while caring for young children. You'll receive text messages and join virtual sessions designed to support both your health and your family.
Pleasanton, CaliforniaAges 21–44 - NCT07396155RecruitingPhase 1/Phase 2
Stem cell therapy for diabetic kidney disease
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
YogyakartaAges 30–65 - NCT06524388Enrolling by invitation
Cognitive training study for older adults with diabetes
This study tests if a special computer-based brain training program can help improve thinking and memory in older adults with diabetes who are at risk for dementia. It might help keep your mind sharp as you age.
BeijingAges 60 years+ - NCT07654374RecruitingPhase 3
Study of a new pill for weight loss and diabetes
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
Birmingham, AlabamaAges 18–79 - NCT06185296Recruiting
Smart diabetes monitoring to help insulin users
This trial tests a smart phone-based system that helps doctors monitor diabetes and adjust insulin treatment. It could make blood sugar control easier for people with type 2 diabetes.
Aalborg, North JutlandAges 18 years+ - NCT06650969Recruiting
Early detection of cognitive decline in type 2 diabetes
This study is looking at ways to catch early thinking and memory changes in people with type 2 diabetes. By joining, you may help doctors learn how to spot problems sooner and find better ways to help.
Nanjing, JiangsuAges 45 years+ - NCT07437157Recruiting
Hong Kong diabetes fatty liver disease study
This research study looks at people with type 2 diabetes to learn more about fatty liver disease. By joining, you may help doctors better understand how these conditions are linked and improve future care.
Hong Kong, New TerritoriesAges 18 years+ - NCT04485871Recruiting
Omega-3 supplements to lower diabetes risk in at-risk adults
This trial tests whether taking omega-3 fatty acids can reduce risk factors for developing diabetes in people with normal cholesterol but other risk factors. You might be asked to follow study visits and dietary/health restrictions for about 33 weeks.
Montreal, QuebecAges 45–74 - NCT07803809RecruitingPhase 1
MWN105 injection for overweight and obesity
This study tests an investigational injection called MWN105 in people who are overweight or obese but do not have diabetes. The goal is to see if it is safe and helps with weight loss.
Kunming, YunnanAges 18–50 - NCT07053319RecruitingPhase 1
Study of diabetes drugs and ketones
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
San Antonio, TexasAges 30–75 - NCT07131410Enrolling by invitation
Hyaluronic acid cream to prevent foot ulcers in diabetes
This trial tests a cream made with hyaluronic acid, a natural substance that helps keep skin moist, to see if it can prevent foot sores in people with type 2 diabetes and nerve damage in their feet. If you have diabetes-related nerve issues and want to protect your feet, this study may be for you.
MálagaAges 18 years+ - NCT07032844Recruiting
Better diabetes care for people with physical disabilities using telehealth
This trial tests if telehealth support through your primary care doctor can help you manage type 2 diabetes and other health conditions. It focuses on people who have a physical disability and need help controlling their blood sugar.
Birmingham, AlabamaAges 18–89 - NCT06031428RecruitingPhase 2
Nurse case management for diabetes in formerly incarcerated Black men
This trial tests a nurse-led program to help formerly incarcerated Black men better manage their type 2 diabetes. The goal is to improve blood sugar control and overall health.
Milwaukee, WisconsinAges 18 years+ - NCT05029115Enrolling by invitation
SGLT2 pill study for atrial fibrillation with type 2 diabetes
This trial tests whether an SGLT2 inhibitor pill can help people who have atrial fibrillation (an irregular heartbeat) and type 2 diabetes. You may be eligible if you’re in the right age range, on diabetes pills only, and meet specific heart and lab criteria.
Yangcheon, SeoulAges 20–80 - NCT07154251Recruiting
Community health workers as diabetes tech coaches for kids
This trial tests whether a community health worker can help Black children with type 1 diabetes use their automated insulin delivery system (a combination of a continuous glucose monitor and an insulin pump) more effectively. Children who are already using or have used this system in the past 3 months may qualify.
Cleveland, OhioAges 5–17 - NCT07019012RecruitingPhase 4
Testing a new every-2-week pill for type 2 diabetes
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
Wuhan, HubeiAges 18 years+ - NCT06220773RecruitingPhase 3
combination treatment for type 2 diabetes and high blood pressure
This study tests two new combination medicines for people who have both type 2 diabetes and high blood pressure. It looks at how well they work and how safe they are. Participants stop their current diabetes and blood pressure drugs during the trial, except for the diabetes drug metformin.
Jakarta, DKI JakartaAges 19 years+ - NCT07556679Enrolling by invitation
Play2Control: Reducing screen time for teens with type 2 diabetes
This study tests whether helping families spend less time watching TV or using screens can improve blood sugar control in children and teens with type 2 diabetes. It may help you manage diabetes better by cutting down on screen time.
Miami, FloridaAges 5–21 - NCT07605390Enrolling by invitation
Prescription help for heart, kidney, and diabetes care
This study tests whether a computer program can help doctors choose the best medicines for people with type 2 diabetes who also have kidney or heart problems. The goal is to improve overall health by making sure patients receive treatments that are proven to help.
Dallas, TexasAges 18 years+
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,059 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.